title: Where do we stand on the relationship between tau biomarkers and mild cognitive impairment?
abstract: We present an editorial on a recent publication by Amlien et al. [2013] in which diffusion tensor imaging (DTI) was used to quantify longitudinal decreases in fractional anisotropy (FA) and increased radial diffusivity (DR) in patients with mild cognitive impairment (MCI). These longitudinal alterations were found to be greater in MCI patients with high cerebrospinal fluid (CSF) tau levels at baseline and greater than healthy controls. Amlien et al. concluded that tau levels were an important early biomarker for predicting rate of disease progression and outcome. The results of this study are an interesting finding for possible predictive use of tau levels in MCI. However, in our assessment, the methodology does not support the conclusion that CSF total tau levels are predictive of MCI progression towards a disease state such as Alzheimer's disease (AD). Further longitudinal study is needed, that includes follow-up neuropsychological assessment and conversion of subjects in the study to AD, to conclude that CSF total tau levels represent a predictive biomarker of MCI progression towards AD.
authors.affiliation: Conquer Chiari Research Center, Department of Mechanical Engineering, University of Akron, OH, USA;
authors.forename: Bryn A
authors.initials: BA
authors.lastname: Martin
authors.forename: Philip A
authors.initials: PA
authors.lastname: Allen
keywords: Alzheimer’s disease; Mild cognitive impairment (MCI); amyloid beta; diffusion tensor imaging (DTI); tau protein
references.citation: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007 Jul;14(4):329-52
references.pmid: 17612812
references.citation: Arch Neurol. 1999 Mar;56(3):303-8
references.pmid: 10190820
references.citation: Psychiatry (Edgmont). 2005 Sep;2(9):30-3
references.pmid: 21120106
references.citation: Lancet Neurol. 2010 Nov;9(11):1118-27
references.pmid: 20934914
references.citation: Acta Psychiatr Scand. 2009 Apr;119(4):252-65
references.pmid: 19236314
references.citation: Behav Neurosci. 1986 Apr;100(2):147-54
references.pmid: 3008780
references.citation: Arch Neurol. 2001 Dec;58(12):1985-92
references.pmid: 11735772
references.citation: Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712
references.pmid: 21852788
references.citation: Alzheimer Dis Assoc Disord. 1987;1(1):3-8
references.pmid: 3331112
references.citation: Radiology. 2013 Jan;266(1):295-303
references.pmid: 23151827